Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 7/20 | 0.62 |
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.62 |
| ▸ | RARB | P10826 | 6/20 | 0.61 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.60 |
| ▸ | MGLL | Q99685 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | RARA | P10276 | 1/20 | 0.48 |
| ▸ | RARG | P13631 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.41 |
| ▸ | TACR2 | P21452 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SHBG | P04278 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4189304 | 0.96 | CA1 (0.61) | LPLLIPGRARBTRPV1MGLL | |
| SCHEMBL9493977 | 0.92 | LPL (0.62) | LPLLIPGRARBTRPV1MGLL | |
| SCHEMBL8767993 | 0.90 | LPL (0.59) | LPLLIPGRARBTRPV1MGLL | |
| SCHEMBL9398982 | 0.84 | RARB (0.68) | LPLLIPGRARBRARARARG | |
| SCHEMBL17070353 | 0.83 | LPL (0.62) | LPLLIPGRARBTRPV1MGLL | |
| SCHEMBL29733595 | 0.83 | LPL (0.62) | LPLLIPGRARBTRPV1MGLL | |
| SCHEMBL15725330 | 0.82 | RARB (0.67) | LPLLIPGRARBRARARARG | |
| SCHEMBL10981922 | 0.82 | RARB (0.70) | LPLLIPGRARBRARARARG | |
| SCHEMBL10977018 | 0.82 | RARB (0.70) | LPLLIPGRARBRARARARG | |
| SCHEMBL10975095 | 0.82 | RARB (0.70) | LPLLIPGRARBRARARARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9868906-B2 | Liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2018-01-16 | — | — | US | disclosed |
| US-9868906-B2 | Liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2018-01-16 | — | — | US | disclosed |
| US-20170240812-A1 | SUBSTITUTED POLYPHENYLS | MERCK PATENT GMBH (DE) | 2017-08-24 | — | — | US | disclosed |
| US-9714383-B2 | Liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-07-25 | — | — | US | disclosed |
| US-9714383-B2 | Liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-07-25 | — | — | US | disclosed |
| US-9714383-B2 | Liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-07-25 | — | — | US | disclosed |
| US-20160168463-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20160168463-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20160168463-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20160137922-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-05-19 | — | — | US | disclosed |
| US-20160137922-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-05-19 | — | — | US | disclosed |
| US-20160137922-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-05-19 | — | — | US | disclosed |
| EP-1223209-B1 | Fluorinated fluorenes and use thereof in liquid crystal mixtures | CLARIANT INT LTD (CH) | 2004-03-03 | — | — | EP | disclosed |
| EP-1223209-A1 | Fluorinated fluorenes and use thereof in liquid crystal mixtures | CLARIANT INTERNATIONAL LTD. (CH) | 2002-07-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137922-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | VCL, LASP1, L1CAM | LPL 1503/4885LIPG 1350/4885RARB 2084/4885 |
| US-20170240812-A1 | SUBSTITUTED POLYPHENYLS | PDS5A, XPA, F2 | LPL 2808/4885LIPG 4227/4885RARB 3043/4885 |
| US-20160168463-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | NLK, NCAPD2, LASP1 | LPL 1669/4885LIPG 1513/4885RARB 2356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.